Oil Investors Wary as Potential Strait of Hormuz Transit Fees Loom Industry Data Chiefs Say Bond Market Suggests Fed May Shift to Tightening Bias Under Warsh Leadership Serve Robotics Drives Physical AI Expansion Through Autonomous Delivery Innovation Legal IP Challenges in Smart Manufacturing Data Ownership Trade Secrets and AI Patent Trends Teslas Latest Software Update Targets Competitive Pressures in China Market CleanSpark CLSK Price Target Raised by Keefe Bruyette Following Operational Strengthening FLY Q1 2026 Earnings EPS Beats Estimates as PreRevenue Aerospace Company Advances Agilysys Q1 2026 Earnings EPS Surpasses Expectations by 244 Amid Concerns Over Revenue Disclosure Southwest Airlines LUV Q1 2026 Earnings EPS Misses Estimates Amid Cost Headwinds CMCM Q4 2025 Earnings Cheetah Mobile Reports WiderThanExpected Loss Amid Revenue Disclosures VICI Q1 2026 Earnings Strong EPS Surprise of 1443 Despite Flat Stock Reaction PXED Q1 2026 Earnings Strong EPS Surprise of 656 Drives Stock Up 327 Blueport Acquisition Ltd Rights BPACR Holds Steady at 018 Amid Low Volume Trading Exodus Movement Inc EXOD Holds Steady at 660 in Quiet Trading Value Line Inc VALU Slips 138 as Stock Tests Key Support Level JBT Marel Corporation JBTM Gains 19 as Stock Tests Key Resistance at 141 Pelican Acquisition Corporation Right PELIR Edges Higher as Speculative Interest Returns Tungray Technologies TRSG Holds Steady at 116 as Traders Eye Key Support and Resistance Levels Putnam Premier Income Trust PPT Edges Higher as Income Investors Weigh Yield Stability Peakstone Realty Trust PKST Holds Steady Near Support Amid Low Volatility Universe Pharmaceuticals Inc UPC Surges 9 as Momentum Builds Near Key Resistance Gores Holdings X Warrants GTENW Plunge 2168 as Support Test Looms Eaton Vance Global Dividend Income Fund ETG Holds Steady Near MidRange as Modest Gains Persist Meta Explores Potential Cloud Computing Business Zuckerberg Says Actelis Networks Q1 2026 Earnings EPS Surprise of 80 Highlights Cost Management Amid Revenue Disclosure Gap Sarepta Therapeutics SRPT Shows Modest Uptick Amid Key Technical Levels